Skip to main content

and
  1. Article

    Open Access

    Metastatic breast cancer: prolongation of survival in routine care is restricted to hormone-receptor- and Her2-positive tumors

    18,000 women die due to metastatic breast cancer in Germany per year. Median survival is 20–28 months after diagnosis. The question we wanted to answer was whether survival has improved in routine care? For th...

    Rudolf Weide, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns in SpringerPlus (2014)

  2. Article

    Open Access

    Adherence assessment of patients with metastatic solid tumors who are treated in an oncology group practice

    Due to the increase of oral agents nonadherence is an emerging challenge in cancer care. We evaluated how well different assessments match and how adherence could be measured in routine care. For this purpose ...

    Stefan Feiten, Rudolf Weide, Vera Friesenhahn, Jochen Heymanns in SpringerPlus (2016)